- Stem Cells for Crohn’s Fistulas: Why a Phase 3 Trial Failed
- Stem Cell Therapy for Heart Failure: What the 2026 Trials Show
- Stem Cell Therapy for Stroke: What the Trials Really Show in 2026
- Stem Cell Therapy for Macular Degeneration: What the 2026 Trials Show
- Stem Cell Therapy for Lupus: What the First Placebo-Controlled MSC Trial Found
- Stem Cell Therapy for Spinal Cord Injury: What Japan’s Stemirac Decision Means
- Stem Cell Therapy for Frailty: What the Laromestrocel Trial Shows
- Stem Cell Transplant for MS: What the Trials Show in 2026
- Stem Cell Therapy for Parkinson’s: Inside the Bemdaneprocel Phase 3 Trial
- Deramiocel HOPE-3: What the Duchenne Stem Cell Trial Shows
- CARTISTEM Enters U.S. Phase 3: Cord Blood Stem Cells for Knee Cartilage
- Ryoncil: The First FDA-Approved MSC Therapy Explained
- Lab-Grown Insulin Cells for Type 1 Diabetes: Inside the Zimislecel Trial
- Stem Cells for Knee Arthritis: What the 2026 Trials Actually Show
- Japan Approves the World’s First iPS Cell Therapies: What It Means (and What It Doesn’t)
- Stem Cell Count vs. Viability: Why Live Cells Beat Big Numbers Every Time
- NAD+ and Stem Cells: Two Approaches to Cellular Renewal | The Stem Cell Club
- Stem Cells May Transform Kidney Disease Treatment | The Stem Cell Club
- MUSE Stem Cells Explained | What They Are & Why They Matter | The Stem Cell Club